Bulls Have Got Some NERV

Dips remain extremely shallow, overall, which may very well galvanize speculators to take a stab at riskier stocks beyond the FANG gang. 

Minerva Neurosciences, Inc., below on the daily timeframes, is a likely candidate. Ever since topping out in June, the biotech has been sporting an attractive base consolidation, especially impressive considering the sloppiness endured by many other biotechs during that time. 

NERV is set to present at a conference on Friday, which may give the name juice to commence a fresh momentum rum higher. 

To be sure, this type of play is inherently much more speculative and riskier than more bread-and-butter bullish charts in the healthcare IT and medical device spaces, for example. 

But I am using it as a gauge as to how confident bulls are feeling after Labor Day with no immediate downside fireworks.